ArticleJournal of cellular and molecular medicine2026
RETRACTION: Spliceosomal Protein E Regulates Neoplastic Cell Growth by Modulating Expression of Cyclin E/CDK2 and G2/M Checkpoint Proteins.
Article in Journal of cellular and molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Retraction of
Authors and funding
0 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
retractionZ. Li and B. M. Pützer, "Spliceosomal Protein E Regulates Neoplastic Cell Growth by Modulating Expression of Cyclin E/CDK2 and G2/M Checkpoint Proteins," Journal of Cellular and Molecular Medicine 12, no. 6a (2008): 2427-2438. https://doi.org/10.1111/j.1582-4934.2008.00244.x. The above article, published online on 16 December 2008 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; and John Wiley & Sons Ltd. A third party reported that comments had been made on PubPeer [1] that raised concerns about potential duplication of bands in Figure 2B. Additional investigation by the publisher found evidence of splicing in Figure 1B and duplication of Actin blots between Ad-GFP in Figure 3A and Ad-Sme pre-mRNA splicing in Figure 5A. The investigation also found evidence of duplications of the Ad SmE Actin blot in Figure 3A and the Ad-GFP p-CDC2 (Tyr15)/CDC2 blot in Figure 5A. Additional potential duplicated bands were detected in Figure 5A. The authors responded to an inquiry by the publisher and stated that the Western blots were generated separately for each experiment and were not intentionally duplicated or altered. However, the original data were no longer available due to the time that had elapsed since publication. The retraction has been agreed to because the evidence of highly similar or duplicated bands fundamentally compromises the editors' confidence in the results presented. The authors disagree with the retraction. References [1] Unregistered Submission and Hydroporus ferrugineus, Comments on "Spliceosomal protein E regulates neoplastic cell growth by modulating expression of cyclin E/CDK2 and G2/M checkpoint proteins," PubPeer, May 2016-October 2025. https://pubpeer.com/publications/216D30610A95CE3D109B97FC1CA64D.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.